NCT02307643 - Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG

MT-1303 Low dose

DRUG

MT-1303 High dose

Trial Locations (14)

Inverstigational site, Bunkyō City

Inverstigational site, Chiba

Inverstigational site, Chūōku

Inverstigational site, Fuchu-shi

Investigational site, Fukuoka

Inverstigational site, Kawagoe-shi

Inverstigational site, Maebashi

Inverstigational site, Meguro-ku

Investigational site, Narashino-shi

Investigational site, Sendai

Inverstigational site, Shimotsuga-gun

Inverstigational site, Shinjuku-ku

Inverstigational site, Tsukuba

Investigational site, Urayasu-shi